Who is sponsoring NCT02947230?

NCT02947230 is sponsored by McMaster University.

What drugs are being tested in NCT02947230?

Interventions in NCT02947230: Tailored Knowledge Translation.

What condition does NCT02947230 study?

NCT02947230 studies Mobility Limitation.

Is NCT02947230 still recruiting?

NCT02947230 is currently completed. Last updated 21 February 2020.

Last reviewed 2020-02-21 · How we verify

NCT02947230

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluating the Impact of the McMaster Optimal Aging Portal on Physical Mobility Outcomes

Completed NA Last updated 21 February 2020

What this trial tests

NA trial testing Tailored Knowledge Translation in Mobility Limitation in 535 participants. Completed in 31 December 2018.

Timeline

7 March 2017

Primary endpoint
1 November 2017

31 December 2018

Quick facts

Lead sponsor	McMaster University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	other
Enrollment	535
Start date	7 March 2017
Primary completion	1 November 2017
Estimated completion	31 December 2018
Sites	1 location across Canada

Drugs / interventions tested

Tailored Knowledge Translation

Conditions studied

Mobility Limitation — all drugs for Mobility Limitation →

Sponsor

McMaster University

Who can join

40 and older, any sex, with Mobility Limitation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The McMaster Optimal Aging Portal (the Portal) was launched in 2014 to increase public access to trustworthy health information. The Portal helps readers to access evidence-based resources; identify trustworthy messages; and understand scientific findings. Now the investigators want to know whether using the Portal changes what people know and do to stay healthy and mobile. This project will help us to: 1. Understand how middle aged and older adults (age 40+) use the Portal to obtain information about maintaining and improving mobility 2. Evaluate whether use of the Portal results in a change in knowledge about maintaining and improving mobility, or change in lifestyle behaviours that may help maintain or improve mobility with age.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

If You Build It, Who Will Come? A Description of User Characteristics and Experiences With the McMaster Optimal Aging Portal.
Neil-Sztramko SE, Farran R, Watson S, Levinson AJ, et al · · 2017 · cited 6× · PMID 29152540 · DOI 10.1177/2333721417737681
A Mobility-Focused Knowledge Translation Randomized Controlled Trial to Improve Physical Activity: Process Evaluation of the Move4Age Study.
Neil-Sztramko SE, Smith-Turchyn J, Richardson J, Dobbins M. · · 2019 · cited 4× · PMID 31223121 · DOI 10.2196/13965
Impact of a Knowledge Translation Intervention on Physical Activity and Mobility in Older Adults (the Move4Age Study): Randomized Controlled Trial.
Neil-Sztramko S, Smith-Turchyn J, Richardson J, Dobbins M. · · 2020 · cited 2× · PMID 32044750 · DOI 10.2196/15125

Verify or expand the search:

Other recruiting trials for Mobility Limitation

Currently open trials in the same condition.

NCT07125378 — Living Independence Through Functional Training · Phase 1, PHASE2 · recruiting
NCT07174973 — Innovative Approaches to Enhance Balance and Neuroplasticity in Multiple Sclerosis · NA · recruiting
NCT07308353 — Comparative Effects Of Exergaming And Otago Exercise On Anticipatory Postural Control And Sensory Integration In Older A · NA · active not recruiting
NCT06686121 — Improving Mobility After Revascularization in Peripheral Artery Disease · Phase 3 · recruiting
NCT06592144 — TESTO-TRIAL: Use of Testosterone in Critically Ill Patients · Phase 4 · active not recruiting

Other McMaster University trials

Trials by the same sponsor.

NCT06231069 — Mixed Exercise Training and Novel Multi-Nutrient Supplementation in Young Adults · NA · withdrawn
NCT07213492 — Multimodal Intervention to Support Hospital-to-Community Transition in Bipolar Disorder · NA · recruiting
NCT07486505 — Mindfulness in Fracture Recovery and Reduction of Opioid Reliance: Evaluating the Feasibility of Implementing a Brief, M · NA · not yet recruiting
NCT07408128 — Partner4Exercise Randomized Controlled Trial · Phase 2, PHASE3 · not yet recruiting
NCT07459777 — Early arthroscoPic Stabilization veRsus rehabilitatiOn of the Shoulder in Adolescents With a trauMatic First-time Anteri · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02947230 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by McMaster University
Last refreshed: 21 February 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02947230.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing